SCHEMBL8784383

SCHEMBL8784383

CCCCCOc1ccc(C(=O)O)o1

nearest known ligand 0.97

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.97
TDP1 Q9NUW8 2/20 0.97
MEN1 O00255 1/20 0.97
TP53 P04637 1/20 0.49
TSHR P16473 1/20 0.49
PLA2G4B P0C869 3/20 0.47
RARB P10826 3/20 0.45
PLA2G2A P14555 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PLA2G4A P47712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11558887 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
SCHEMBL13193431 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
Tofa SCHEMBL543676 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
SCHEMBL11561346 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
SCHEMBL992112 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
SCHEMBL9060429 0.98 MEN1 (1.00) KMT2ATDP1MEN1TP53TSHR
Tofa SCHEMBL11555343 0.97 MEN1 (0.97) KMT2ATDP1MEN1TP53TSHR
SCHEMBL10669926 0.90 TDP1 (0.84) KMT2ATDP1MEN1TP53TSHR
SCHEMBL10669914 0.90 TDP1 (0.84) KMT2ATDP1MEN1TP53TSHR
SCHEMBL10669917 0.90 TDP1 (0.84) KMT2ATDP1MEN1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107417651-A A kind of method for preparing 2,5 furandicarboxylic acids and its derivative 合肥利夫生物科技有限公司 2017-12-01 CN disclosed
EP-0595995-B1 ARYLAMIDOALKYL- AND ARYLAMINOALKYL-N-HYDROXYUREA COMPOUNDS AND -N-HYDROXYFORMAMIDE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1997-01-15 EP disclosed
US-5514702-A Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity ABBOTT LABORATORIES (US) 1996-05-07 US disclosed
EP-0595995-A4 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1994-08-24 EP disclosed
EP-0595995-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY. ABBOTT LAB (US) 1994-05-11 EP disclosed
WO-1993002037-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1993-02-04 WO disclosed